Pharma Stocks
-
Agios Pharmaceuticals (AGIO) Wins Priority Review, Is The Stock Now Fully Valued?
Agios Pharmaceuticals (AGIO) is back in focus after the U.S. Food and Drug Administration accepted its supplemental New Drug Application…
Read More » -
ELTP vs. CPIX: Which Pharma Stock Is the Better Buy Right Now? – July 15, 2026
Specialty pharmaceutical companies continue to operate in a competitive healthcare environment influenced by evolving regulatory standards, product innovation and demand…
Read More » -
Is Silo Pharma, Inc. (SILO) Stock an AI Opportunity After NVIDIA Partnership Boosts QwikAgents Platform?
We recently compiled a list of the 7 Best Psychedelic Stocks to Buy According to Analysts. Silo Pharma, Inc. (NASDAQ:SILO)…
Read More » -
Sun Pharma to manufacture and market Semaglutide in South Africa; shares trade in green
Upstox Securities Pvt. Ltd.: SEBI Registration No. INZ000315837 | NSE TM Code: 13942 | BSE TM Code: 6155 | CDSL…
Read More » -
Shuttle Pharma stock jumps 41% as turnover hits 82 times its share base
NEW YORK, July 14, 2026, 16:13 EDT Shuttle Pharmaceuticals Holdings, Inc. NASDAQ:SHPH shares closed 40.5% higher at $4.16 on Tuesday…
Read More » -
The First Commercial Operating System for Pharma, Powered by Semmelweis
Built by 75. Proven by 5. Launched to the industry. Daily Command orchestrates the entire commercialization journey — physician awareness…
Read More » -
Donald Trump’s Drug-Pricing Deals Are Reshaping Big Pharma — Here’s What That Means for Pfizer, AbbVie, and Bristol Myers Squibb
Drug pricing has been hanging over the pharmaceutical industry for years, and the Trump administration didn’t eliminate that pressure. It…
Read More » -
FRE) Advances on Product Development Momentum
Key Highlights: • Firebrick Pharma shares climbed 7.14% to AUD 0.03 during the session.• Trading turnover reached approximately AUD 9,196.•…
Read More » -
Does Vertex’s Acquisition of Crinetics Pharmaceuticals Make the Stock a No-Brainer Buy?
Key Points Vertex is buying Crinetics Pharmaceuticals for $10 billion. The acquisition could add up to $5 billion in revenue.…
Read More » -
Zealand Pharma – Transactions related to share buy-back program (week 28, 2026)
Zealand Pharma Company announcement No. 32 / 2026 Zealand Pharma – Transactions related to share buy-back program (week 28, 2026)…
Read More »